Our research focuses on structural and functional characterization of ROR1/ROR2 receptor pseudokinases from the non-canonical Wnt pathway. We are aiming to understand how these receptors function in normal and disease conditions. Since elevated expression of both ROR1 and ROR2 is associated with cancer development and treatment resistance, we want to explore how we can improve cancer treatment by targeting their expression in single or combinatorial therapies.